Future prostate cancer treatment could be more effective due to the development of robot-assisted technology.
Scientists at Henry Ford Hospital's Vattikuti Urology Institute compared the success rates of robot-assisted radical prostatectomy (RARP) to the standard surgical procedure - open radical prostatectomy (ORP).
The found that RARP patients were less likely to need a blood transfusion, a prolonged stay in hospital and have cardiac, respiratory or vascular complications post-surgery.
Doctors explained that RARP is much less invasive that ORP, which requires a large incision to be made to remove the entire tumour prostate.
Mani Menon, director of the clinical institute, said that 98 per cent of RARP patients leave hospital within 24 hours of the procedure and only two percent experience a complication.
According to Cancer Research UK, around 100 men in the UK are diagnosed with the disease every day, making it the most common form of cancer among British males.